Sonoma Pharma EU

About Sonoma Pharma EU

Sonoma Pharmaceuticals offers safe early-intervention solutions that provide fast relief and are free from side effects and other limitations. Born in northern California, Sonoma Pharmaceuticals began with Microcyn® Technology-based (HOCl) products for wound care patients. After significant success helping millions of patients, Sonoma has since expanded into dermatology, eye care, nasal care and oral care. Today, Sonoma is the global leader in HOCl based health care solutions. Sonoma Pharmaceuticals Netherlands B.V. -a wholly owned subsidiary of Sonoma Pharmaceuticals, Inc.- was founded in 2004 and directs the marketing, sales and customer service, maintains customers’ satisfaction, generats market awareness and supports the commercialization of Microcyn® Technology based products throughout Europe.

Keywords

• Acne Treatment
• Anti-Inflammatory
• Anti-Microbial
• Athopic Dermatitis Treatment
• Dermatology
• Disinfection
• Eye-Care
• Healing
• Healthcare
• Hypochlorite
• Hypochlorous Acid
• Medical Device
• Nasal
• Natural
• Natural Healing
• Oral Care
• Ph Neutral
• Scar Treatment
• Woundcare

Address

• Headquarters

  Boven de Wolfskuil6045BW HertenLimburg, Netherlands